Flexion Therapeutics Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), the most common form of arthritis. The company’s approved product, ZILRETTA ®, is the first and only extended-release, intra-articular, or IA (meaning in the joint), injection indicated for the management of OA knee pain. ZILRETTA is a non-opioid therapy that employs a proprietary microsphere technology to provide effective pain relief.
No news available
Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.
